ATS View
한국어

Kwangdong Pharmaceutical KRX:009290KOSPI

광동제약 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h12
Articles, 7 days23
DART filings, 7 days0
Articles tracked23since Sep 11

In Q2 2026, Kwangdong Pharmaceutical reported revenue of ₩440bn, up 3.4% year on year, and operating profit of ₩2.8bn. Kwangdong Pharmaceutical (광동제약) appeared in 23 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 14 with 22 articles. The most common catalyst was contracts & orders (1). It was most often mentioned alongside Tomatosystem, Chong Kun Dang Pharmaceutical and Hanmi Pharm.

Kwangdong Pharmaceutical quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩440bn+3.4%₩2.8bn₩3.2bn
Q1 2026₩411bn+8.8%₩7.5bn₩4.9bn
Q4 2025 derived₩412bn+5.4%₩12.3bn₩3.8bn
Q3 2025₩445bn+4.7%₩10.9bn₩11.1bn
Q2 2025₩425bn+3.0%₩4.5bn₩2.4bn
Q1 2025₩378bn-8.5%₩3.3bn₩4.1bn
Q4 2024 derived₩391bn+1.7%₩6.7bn₩12.8bn
Q3 2024₩425bn+6.7%₩1.4bn₩9.0bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

Kwangdong Pharmaceutical top stories 2 weeks, by number of outlets

  1. 1
    광동제약 '비타500 이온킥 제로', 출시 8개월 만에 1000만개 판매
    12 outlets · 12 articlesFirst report Sep 14 08:28 머니투데이
  2. 2
    [제약소식]광동제약, ‘비타500 이온킥 제로’ 누적 판매 1000만 개 넘어서
    7 outlets · 7 articlesFirst report Sep 14 08:32 웹이코노미
  3. 3
    [기업 레이더] 광동제약, 삼다수·가다실 비중 44%…자체 품목 한계 속 희귀약 체질전환?
    1 outlets · 1 articlesFirst report Sep 15 06:00 메디팜스투데이
  4. 4
    제로 칼로리에 비타민C까지…광동제약 ‘비타500 이온킥 제로’ 라인업 확장 돌입
    1 outlets · 1 articlesFirst report Sep 14 15:33 서울신문
  5. 5
    [제약건기식]한미약품 '앤 시리즈', 캐릭터로 인기 일반약 브랜드 통합 外 종근당·광동제약
    1 outlets · 1 articlesFirst report Sep 14 15:40 글로벌경제신문Hanmi PharmChong Kun Dang Pharmaceutical
  6. 6
    [IB토마토]광동제약, 퍼스트 제네릭 따냈지만…약가인하에 실익 줄어드나
    1 outlets · 1 articlesFirst report Sep 14 17:10 뉴스토마토Order / supply contractTomatosystem

Latest Kwangdong Pharmaceutical news Korean headlines